Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Inventory is also known as Days Sales of Inventory (DSI). Centogene NV's Average Total Inventories for the
six
months ended in Dec. 2023 was $2.50 Mil. Centogene NV's Cost of Goods Sold for the
six
months ended in Dec. 2023 was $16.97 Mil.
Hence, Centogene NV's Days Inventory for the
six
months ended in Dec. 2023 was 26.85.
The historical rank and industry rank for Centogene NV's Days Inventory or its related term are showing as below:
CNTGF's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 64.86 * Ranked among companies with meaningful Days Inventory only.
Centogene NV's Days Inventory
increased
from Dec. 2022 (24.68) to Dec. 2023 (26.85).
It might indicate that Centogene NV's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Centogene NV's Inventory Turnover for the
six
months ended in Dec. 2023 was 6.80.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Centogene NV's Inventory-to-Revenue for the
six
months ended in Dec. 2023 was 0.10.
Centogene NV (OTCPK:CNTGF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Centogene NV's Inventory Turnover for the
six
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Centogene NV's Inventory to Revenue for the
six
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Centogene NV Days Inventory Related Terms
Centogene NV Days Inventory Historical Data
* Premium members only.
The historical data trend for Centogene NV's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CNTGF vs ISPC, CHEK, FUNI: Days Inventory Comparison
For the Diagnostics & Research subindustry, Centogene NV's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centogene NV Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's Days Inventory distribution charts can be found below:
* The bar in red indicates where Centogene NV's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centogene NV (CNTGF) has a Days Inventory of 26.85 as of Dec. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Centogene NV and its competitors.
Is Centogene NV's Days Inventory too high?
Centogene NV's current Days Inventory is 26.85. The Medical Diagnostics & Research industry median Days Inventory is 64.86. Centogene NV's value of 26.85 is 58.6% below this industry median. Overall, Centogene NV has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Centogene NV's Days Inventory compare to ISPC and CHEK?
Centogene NV's Days Inventory of 26.85 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Inventory is 64.86. Centogene NV's value of 26.85 is 58.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 64.86, based on 180 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centogene NV's current Days Inventory of 26.85 is 58.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Centogene NV and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 64.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centogene NV's current Days Inventory is 26.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centogene NV stock overvalued right now?
Centogene NV (CNTGF) has a current Days Inventory of 26.85. The current Days Inventory is 26.85 and 58.6% below the Medical Diagnostics & Research industry median of 64.86. Centogene NV's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Centogene NV (CNTGF), the current Days Inventory is 26.85 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
12GF Score
Get the complete analysis for CNTGF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CNTGF has been successfully added to your 
